TARA FY 2021 Earnings — Protara Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TARAProtara Therapeutics, Inc.

$211M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$47M

Net Income

-$47M

EPS (Diluted)

$-4.20

Cash Flow

Operating Cash Flow

-$35M

Free Cash Flow

-$35M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$173M

Total Liabilities

$11M

Stockholders' Equity

$162M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$196,000	+100.0%
Operating Income	-$47M	-$34M	-37.9%
Net Income	-$47M	-$34M	-39.1%